< Back to previous page
Researcher
Yannick Debing
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 2011 → 30 Sep 2016
Projects
1 - 1 of 1
- Towards the development of potent and selective inhibitors of hepatitis E virus.From1 Oct 2011 → 30 Sep 2015Funding: FWO fellowships
Publications
1 - 10 of 26
- Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver(2017)
Authors: Yannick Debing, Johan Neyts
Pages: 920 - 929 - Viral macro domains reverse protein ADP-ribosylation(2016)
Authors: Yannick Debing, Johan Neyts
Pages: 8478 - 8486 - A rat model for hepatitis E virus(2016)
Authors: Yannick Debing, Niraj Mishra, Erik Verbeken, Kaat Ramaekers, Kai Dallmeier, Johan Neyts
Pages: 1203 - 1210 - Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity(2016)
Authors: Yannick Debing, Kai Dallmeier, Johan Neyts
Pages: 499 - 508 - Update on hepatitis E virology: Implications for clinical practice(2016)
Authors: Yannick Debing, Johan Neyts
Pages: 200 - 212 - Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells(2016)
Authors: Yannick Debing, Johan Neyts
Pages: 512 - 521 - Reply(2016)
Authors: Yannick Debing, Johan Neyts
Pages: 1690 - 1691 - Stem cell-derived hepatocytes: A novel model for hepatitis E virus replication(2016)
Authors: Nicky Helsen, Yannick Debing, Jan Paeshuyse, Kai Dallmeier, Ruben Boon, Christel Claes, Johan Neyts, Catherine Verfaillie
Pages: 565 - 573 - Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined With Ribavirin(2016)
Authors: Yannick Debing, Johan Neyts
Pages: 82 - 85 - The future of antivirals: broad-spectrum inhibitors(2015)
Authors: Yannick Debing, Johan Neyts, Leen Delang
Pages: 596 - 602